Showing results (351-360 of 478) with videos related to
Sort By:
Pageof 48
American Heart Journal|April 29, 2006
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trialMatthews Chacko, A Michael Lincoff, Katherine E Wolski, et al.Lancet (London, England)|September 6, 2003
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathyArman T Askari, Samuel Unzek, Zoran B Popovic, et al.Plos Medicine|March 14, 2018
Validation of a genetic risk score for atrial fibrillation: A prospective multicenter cohort studyEvan D Muse, Nathan E Wineinger, Emily G Spencer, et al.European Heart Journal|July 1, 2005
Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromesStefano Savonitto, Mauricio G Cohen, Alessandro Politi, et al.Cell|April 27, 2016
Whole-Genome Sequencing of a Healthy Aging CohortGalina A Erikson, Dale L Bodian, Manuel Rueda, et al.Journal of the American College of Cardiology|June 21, 2005
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trialHitinder S Gurm, Ian J Sarembock, Dean J Kereiakes, et al.The American Journal of Medicine|January 25, 2006
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarctionRajendra H Mehta, David Marks, Robert M Califf, et al.The American Journal of Cardiology|July 16, 2003
Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trialIvan P Casserly, Eric J Topol, Gang Jia, et al.American Heart Journal|July 3, 2002
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteriesR David Anderson, Harvey D White, E Magnus Ohman, et al.American Heart Journal|January 7, 2003
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trialsDavid Hasdai, Eric J Topol, Rakhi Kilaru, et al.Pageof 48